Cargando…
Safety and efficacy of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a randomized controlled trial
Current allergen-specific immunotherapy (AIT) for pollinosis requires long-term treatment with potentially severe side effects. Therefore, development of an AIT that is safe and more convenient with a shorter regimen is needed. This prospective, double-blind, placebo-controlled trial randomized 55 p...
Autores principales: | Murakami, Daisuke, Sawatsubashi, Motohiro, Omori, Hirofumi, Saito, Akira, Kato, Akio, Komune, Shizuo, Nakagawa, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387405/ https://www.ncbi.nlm.nih.gov/pubmed/28397833 http://dx.doi.org/10.1038/srep46142 |
Ejemplares similares
-
Asthma in Patients With Japanese Cedar Pollinosis
por: Tanaka, Akihiko, et al.
Publicado: (2012) -
Japanese cedar pollinosis: Discovery, nomenclature, and epidemiological trends
por: SAITO, Yozo
Publicado: (2014) -
Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status
por: Sakurai, Daiju, et al.
Publicado: (2022) -
Japanese Cedar (Cryptomeria japonica) Pollinosis in Jeju, Korea: Is It Increasing?
por: Lee, Jaechun, et al.
Publicado: (2015) -
Sublingual Immunotherapy for Japanese Cedar Pollinosis Attenuates Asthma Exacerbation
por: Kikkawa, Sayaka, et al.
Publicado: (2019)